These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3711250)

  • 1. Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire.
    Maricq HR; Weinrich MC; Keil JE; LeRoy EC
    J Chronic Dis; 1986; 39(6):423-7. PubMed ID: 3711250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Raynaud phenomenon in the adult population of South Carolina.
    Weinrich MC; Maricq HR; Keil JE; McGregor AR; Diat F
    J Clin Epidemiol; 1990; 43(12):1343-9. PubMed ID: 2254771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographic variation in the prevalence of Raynaud's phenomenon: Charleston, SC, USA, vs Tarentaise, Savoie, France.
    Maricq HR; Carpentier PH; Weinrich MC; Keil JE; Franco A; Drouet P; Ponçot OC; Maines MV
    J Rheumatol; 1993 Jan; 20(1):70-6. PubMed ID: 8441170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of scleroderma spectrum disorders in the general population of South Carolina.
    Maricq HR; Weinrich MC; Keil JE; Smith EA; Harper FE; Nussbaum AI; LeRoy EC; McGregor AR; Diat F; Rosal EJ
    Arthritis Rheum; 1989 Aug; 32(8):998-1006. PubMed ID: 2788424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms of Raynaud's phenomenon in an inner-city African-American community: prevalence and self-reported cardiovascular comorbidity.
    Gelber AC; Wigley FM; Stallings RY; Bone LR; Barker AV; Baylor I; Harris CW; Hill MN; Zeger SL; Levine DM
    J Clin Epidemiol; 1999 May; 52(5):441-6. PubMed ID: 10360339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raynaud phenomenon.
    Porter SB; Murray PM
    J Hand Surg Am; 2013 Feb; 38(2):375-7; quiz 378. PubMed ID: 23158111
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of primary Raynaud phenomena in young females.
    Olsen N; Nielsen SL
    Scand J Clin Lab Invest; 1978 Dec; 38(8):761-4. PubMed ID: 741205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Finger first white, then blue, finally red. How to recognize and treat Raynaud disease].
    Ahmadi-Simab K; Hellmich B; Gross WL
    MMW Fortschr Med; 2006 Feb; 148(7):55-6. PubMed ID: 16529366
    [No Abstract]   [Full Text] [Related]  

  • 9. Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison.
    Maricq HR; Carpentier PH; Weinrich MC; Keil JE; Palesch Y; Biro C; Vionnet-Fuasset M; Jiguet M; Valter I
    J Rheumatol; 1997 May; 24(5):879-89. PubMed ID: 9150076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.
    Maricq HR; Weinrich MC; Valter I; Palesch YY; Maricq JG
    J Rheumatol; 1996 Dec; 23(12):2068-78. PubMed ID: 8970043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Item 327--Raynaud phenomenon].
    CEDEF
    Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A223-6. PubMed ID: 23176853
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report.
    Harper FE; Maricq HR; Turner RE; Lidman RW; Leroy EC
    Am J Med; 1982 Jun; 72(6):883-8. PubMed ID: 7091158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infrared functional imaging applied to Raynaud's phenomenon.
    Merla A; Di Donato L; Di Luzio S; Farina G; Pisarri S; Proietti M; Salsano F; Romani GL
    IEEE Eng Med Biol Mag; 2002; 21(6):73-9. PubMed ID: 12613214
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of Raynaud phenomenon in Tartu and Tartumaa, southern Estonia.
    Valter I; Maricq HR
    Scand J Rheumatol; 1997; 26(2):117-24. PubMed ID: 9137327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operating hand-held vibrating tools and prevalence of white fingers.
    Mirbod SM; Inaba R; Iwata H
    Nagoya J Med Sci; 1994 May; 57 Suppl():173-83. PubMed ID: 7708099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis.
    Herrick AL; Clark S
    Ann Rheum Dis; 1998 Feb; 57(2):70-8. PubMed ID: 9613334
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of Raynaud phenomenon in systemic sclerosis.
    Sinnathurai P; Schrieber L
    Intern Med J; 2013 May; 43(5):476-83. PubMed ID: 23347192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Office evaluation and treatment of Raynaud's phenomenon.
    Bolster MB; Maricq HR; Leff RL
    Cleve Clin J Med; 1995; 62(1):51-61. PubMed ID: 7859402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Raynaud disease].
    Pettersson T
    Duodecim; 2005; 121(22):2411-9. PubMed ID: 16457072
    [No Abstract]   [Full Text] [Related]  

  • 20. Major clinical diagnoses found among patients with Raynaud phenomenon from the general population.
    Maricq HR; McGregor AR; Diat F; Smith EA; Maxwell DB; LeRoy EC; Weinrich MC
    J Rheumatol; 1990 Sep; 17(9):1171-6. PubMed ID: 2290157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.